In conclusion, our study indicates that TPH2, the predominant TPH isoform in the CNS, is dramatically upregulated in adipocytes by obesity-induced hyperinsulinemia altering systemic metabolism, and adipocyte-specific inhibition of TPH2 could be a promising therapeutic intervention for DIO and its metabolic complications. The gene discussed is TPH1; the disease is Obesity.